Milestone Pharmaceuticals (MIST) Stock Highlights

1.55 | +1.31%

2024-09-19 06:14:00

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT.

Statistics

Range Today

1.51 1.56

Volume Today 98.5K

Range 1 Year

1.12 3.52

Volume 1 Year 53.63M

Range 3 Year

1.12 9.85

Volume 3 Year 147.25M

Range 10 Year

1.12 27.95

Volume 10 Year 634.29M

Highlights

Market Capitalization 80.97M (small)

Floating Shares 52.79M

Current Price 1.55

Price To Earnings -1.47

Price To Book 3.15

Earnings Per Share -1.01

Payout Ratio 0%

Performance

Latest +1.31%

1 Month +17.42%

3 Months +7.64%

6 Months +7.64%

1 Year -50.79%

3 Years -72.85%

5 Years -92.9%

10 Years -90.07%

Benchmarks

Market Capitalization

278 / 368

Gross Profits

110 / 278

Total Revenue

203 / 300

Total Rank

199 / 368

Free Cashflow

171 / 352

Performance 5 years

317 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.